Meloxidyl 1.5 mg/ml - Oral suspension
Meloxidyl 1.5 mg/ml - Oral suspension
Authorised
- Meloxicam
Product identification
Medicine name:
Meloxidyl 1.5 mg/ml - Oral suspension
Active substance:
- Meloxicam
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Meloxicam1.50/milligram(s)1.00Bottle
Pharmaceutical form:
-
Oral suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QM01AC06
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Liechtenstein
-
Lithuania
-
Luxembourg
-
Malta
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
Available in:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Luxembourg
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
Package description:
- Packaging:Bottle (HDPE) with measuring syringe (LDPE), Package_size:1 bottle + 2 syringes, Content:10 ml
- Packaging:Bottle (HDPE) with measuring syringe (LDPE), Package_size:1 bottle + 2 syringes, Content:32 ml
- Packaging:Bottle (HDPE) with measuring syringe (LDPE), Package_size:1 bottle + 2 syringes, Content:100 ml
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
- Vetem S.p.A.
- Ceva Sante Animale
Responsible authority:
- European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet